Breast Cancer Stocks List



Recent Signals

Date Stock Signal Type
2021-04-13 ARAV Narrow Range Bar Range Contraction
2021-04-13 ARAV Bullish Engulfing Bullish
2021-04-13 ATOS Hammer Candlestick Bullish
2021-04-13 ATOS Lizard Bullish Bullish Day Trade Setup
2021-04-13 AVEO Crossed Above 200 DMA Bullish
2021-04-13 AVEO Narrow Range Bar Range Contraction
2021-04-13 AZN 50 DMA Resistance Bearish
2021-04-13 AZN Bollinger Band Squeeze Range Contraction
2021-04-13 BCTX Calm After Storm Range Contraction
2021-04-13 BIOC Narrow Range Bar Range Contraction
2021-04-13 BPTH 1,2,3 Pullback Bullish Bullish Swing Setup
2021-04-13 BPTH Lower Bollinger Band Walk Weakness
2021-04-13 CHRS New 52 Week Low Weakness
2021-04-13 CHRS New Downtrend Bearish
2021-04-13 CLDX Narrow Range Bar Range Contraction
2021-04-13 CLDX NR7 Range Contraction
2021-04-13 CLSN Stochastic Buy Signal Bullish
2021-04-13 CLSN Crossed Above 200 DMA Bullish
2021-04-13 CLVS Narrow Range Bar Range Contraction
2021-04-13 CLVS MACD Bearish Centerline Cross Bearish
2021-04-13 CRIS 20 DMA Resistance Bearish
2021-04-13 CRIS 50 DMA Support Bullish
2021-04-13 CTIC Doji - Bullish? Reversal
2021-04-13 CTIC Hammer Candlestick Bullish
2021-04-13 CTIC Lizard Bullish Bullish Day Trade Setup
2021-04-13 GENE Narrow Range Bar Range Contraction
2021-04-13 GENE Calm After Storm Range Contraction
2021-04-13 GENE 20 DMA Resistance Bearish
2021-04-13 GLSI Calm After Storm Range Contraction
2021-04-13 GLSI 50 DMA Support Bullish
2021-04-13 GLSI Fell Below 20 DMA Bearish
2021-04-13 GTHX NR7 Range Contraction
2021-04-13 HOLX Crossed Above 50 DMA Bullish
2021-04-13 HOLX Pocket Pivot Bullish Swing Setup
2021-04-13 HOLX Expansion Pivot Buy Setup Bullish Swing Setup
2021-04-13 HOLX Bollinger Band Squeeze Range Contraction
2021-04-13 ICAD Pocket Pivot Bullish Swing Setup
2021-04-13 IMCR Stochastic Buy Signal Bullish
2021-04-13 IMCR Lower Bollinger Band Walk Weakness
2021-04-13 IMGN Lower Bollinger Band Walk Weakness
2021-04-13 IMGN Stochastic Buy Signal Bullish
2021-04-13 ISR Stochastic Buy Signal Bullish
2021-04-13 MACK Crossed Above 20 DMA Bullish
2021-04-13 MACK Slingshot Bearish Bearish Swing Setup
2021-04-13 MACK MACD Bullish Signal Line Cross Bullish
2021-04-13 NAVB NR7 Range Contraction
2021-04-13 NAVB Jack-in-the-Box Bearish Bearish Swing Setup
2021-04-13 NAVB Lower Bollinger Band Walk Weakness
2021-04-13 NAVB Narrow Range Bar Range Contraction
2021-04-13 NKTR Stochastic Buy Signal Bullish
2021-04-13 OCX Fell Below 20 DMA Bearish
2021-04-13 OCX Fell Below 50 DMA Bearish
2021-04-13 OLMA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-13 PDSB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-13 PDSB 180 Bullish Setup Bullish Swing Setup
2021-04-13 SLRX Stochastic Reached Oversold Weakness
2021-04-13 SLRX Narrow Range Bar Range Contraction
2021-04-13 SLRX Lower Bollinger Band Walk Weakness
2021-04-13 SLS NR7 Range Contraction
2021-04-13 SLS Narrow Range Bar Range Contraction
2021-04-13 SNDX Lower Bollinger Band Walk Weakness
2021-04-13 SNDX Stochastic Reached Oversold Weakness
2021-04-13 VSTM Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-13 VSTM 180 Bullish Setup Bullish Swing Setup
2021-04-13 ZIOP Pocket Pivot Bullish Swing Setup
2021-04-13 ZIOP 200 DMA Support Bullish
2021-04-13 ZIOP New Downtrend Bearish
2021-04-13 ZNTL MACD Bullish Signal Line Cross Bullish
2021-04-13 ZNTL Crossed Above 200 DMA Bullish
2021-04-13 ZNTL Crossed Above 50 DMA Bullish
2021-04-13 ZNTL Crossed Above 20 DMA Bullish
2021-04-13 ZNTL Pocket Pivot Bullish Swing Setup

Recent News for Breast Cancer Stocks

Date Stock Title
Apr 14 AZN UPDATE 1-Thailand reports daily record of over 1,300 new coronavirus cases
Apr 14 AZN UPDATE 1-AstraZeneca's drug Tagrisso gets China nod for early lung cancer
Apr 14 AZN EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - paper
Apr 14 AZN Johnson & Johnson saga reveals critical strengths in the U.S. COVID-19 mass-vaccination strategy — and its weaknesses
Apr 14 AZN Need to Continue Wearing Mask After Vaccination, Doctor Says
Apr 14 AZN Political polarisation hampers Spain’s pandemic response
Apr 14 AZN India seeks vaccine boost with Russian jab deal as Covid cases soar
Apr 13 AZN UK trial on switching COVID-19 vaccines adds Moderna and Novavax shots
Apr 13 AZN Rare blood clots tied to J&J’s COVID-19 shot are similar to issues with AstraZeneca’s vaccine, FDA official says
Apr 13 AZN RPT-U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clots
Apr 13 AZN U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clots
Apr 13 AZN JNJ COVID-19 vaccine use halted in South Africa
Apr 13 AZN FDA, CDC Officials Discuss Johnson & Johnson Vaccine: A 'Pause Recommendation', Resolution Timeline And Advisory
Apr 13 AZN Doctor on J&J vaccine pause: CDC is letting the public know they are taking any side effect seriously
Apr 13 HOLX Danaher Corporation's guidance raise points to post-COVID lab recovery: Keybanc
Apr 13 AZN We’re not seeing anything that is outside the bounds of what we typically see with new vaccines: Dr. Howard Forman

Apr 13 AZN Why Shares Of Moderna Are Up By 7% Today?
Apr 13 AZN Doctor on J&J vaccine: 'We’re talking about one in a million for these clots'
Apr 13 AZN JNJ COVID-19 vaccine pause could be a “matter of days”: FDA
Apr 13 AZN UPDATE 3-EU seeking clarification from J&J after rollout delay news

Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.Risk factors for developing breast cancer include being female, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, prior history of breast cancer, and family history. About 5–10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas. In addition, there are more than 18 other sub-types of breast cancer. Some cancers, such as ductal carcinoma in situ, develop from pre-invasive lesions. The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump. Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments are most likely to be effective.The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm. A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age, and the organization recommends screening every two years in women 50 to 74 years old. The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it. Surgical removal of both breasts is another preventative measure in some high risk women. In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy. Types of surgery vary from breast-conserving surgery to mastectomy. Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.Outcomes for breast cancer vary depending on the cancer type, extent of disease, and person's age. Survival rates in the developed world are high, with between 80% and 90% of those in England and the United States alive for at least 5 years. In developing countries survival rates are poorer. Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases. In 2012 it resulted in 1.68 million new cases and 522,000 deaths. It is more common in developed countries and is more than 100 times more common in women than in men.

More about Breast Cancer
Browse All Tags